Antiplasmodial, Antimalarial and Hemozoin Inhibitory Potential of Nauclea pobeguinii Rootbark Methanol Extract
DOI:
https://doi.org/10.26538/tjdr/v3i3.1Keywords:
Nauclea pobeguinii, β-carboline alkaloids, Antiplasmodial, Antimalarial, Heme biocrystallization, Oral pharmacokineticsAbstract
Purpose: Nauclea pobeguinii is one of the medicinal plants commonly used to manage malaria in Nigeria. This study sought to assess its antimalarial mechanism of action by evaluating its phytochemical content, antiplasmodial activity, cytotoxicity, and heme detoxification potential. Furthermore, we conducted an in silico ADME of the β-carboline alkaloids reported to be responsible for it’s their antimalarial activity. Phytochemical screening revealed the presence of several phytometabolites, including alkaloids. The extract was non-toxic to HUH cells and inactive against the malaria parasite in culture. Given its in vitro inactivity, we assessed its antimalarial activity and probed for inhibition of heme biocrystallization in vivo. Methods: Blood was taken from the hearts of 3 mice each in the control and study groups, and the blood was lysed to release the parasites, whose parasitophorous vacuole and digestive vacuole (DV) membranes were disrupted, releasing DV contents from which free heme was quantified. Results: There was a dose-dependent decrease in parasitemia and hemozoin concentration, suggesting that higher doses of the extract led to greater inhibition of heme biocrystallization. However, on day 10, parasitemia levels in N. pobeguinii-treated mice reached levels comparable to those of untreated controls, negatively impacting mouse survival. Our in-silico study revealed that the N. pobeguinii-derived β-carboline alkaloids are not only substrates of Permeability glycoprotein but also of several Cytochrome P450 enzymes.. Conclusion: The result of our study thus suggests that while N. pobeguinii may kill the malaria parasite by inhibiting heme biocrystallization; its antimalarial activity may be impacted by poor oral pharmacokinetics.Downloads
References
1. WHO. World Malaria Report 2025. Available at: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2025 [Accessed 18 Apr 2026].
2. Hemingway J, Ranson H, McCarroll L. Insecticide resistance in Anopheles mosquitoes and its impact on malaria control. Lancet Infect Dis. 2022; 22(5): 470-478.
3. Erhunse N, Sahal D. Protecting future antimalarials from the trap of resistance: Lessons from artemisinin-based combination therapy (ACT) failures. J Pharm Anal. 2021; 11 (2021): 541- 554
4. Dorn M, Patel V, Zhang J. Natural products in antimalarial drug discovery: a focus on plant, microorganism, and marine-derived compounds. Phytochem Rev. 2022; 21(5): 989-1003.
5. Haudecoeur R, Peuchmaura M, Pérèsa B, Rome M, Taïwe GS, Boumendjel A, Boucherle B. Traditional uses, phytochemistry and pharmacological properties of African Nauclea species: A review. J Ethnopharmacol. 2017; 212: 106-136. https://doi.org/10.1016/j.jep.2017.10.011
6. Mesia K, Cimanga K, Tona L, Mampunza MM, Ntamabyaliro N, Muanda T, Muyembe T, Totté J, Mets T, Pieters L. Assessment of the short-term safety and tolerability of a quantified 80% ethanol extract from the stem bark of Nauclea pobeguinii (PR 259 CT1) in healthy volunteers: a clinical phase I study. Planta Med. 2011; 77: 111–116.
7. Mesia K, Tona L, Mampunza MM, Ntamabyaliro N, Muanda T, Muyembe T, Cimanga K, Totté J, Mets T, Pieters L. Antimalarial efficacy of a quantified extract of Nauclea pobeguinii stem bark in human adult volunteers with diagnosed uncomplicated falciparum malaria. Part 1: a clinical phase IIA trial. Planta Med. 2012a; 78: 211–218.
8. Mesia K, Tona L, Mampunza MM, Ntamabyaliro N, Muanda T, Muyembe T, Musuamba T, Mets T, Cimanga K, Totté J. Antimalarial efficacy of a quantified extract of Nauclea pobeguinii stem bark in human adult volunteers with diagnosed uncomplicated falciparum malaria. Part 2: a clinical phase IIB trial. Planta Med. 2012b; 78: 853–860.
9. Anthony MP, Burrows JN, Duparc S, Moehrle JJ, Wells TNC. The global pipeline of new medicines for the control and elimination of malaria. Malar J. 2012; 11:316.
10. Harborne JB. Phytochemical methods - A guide to modern techniques of plant analysis, 1973; third ed. Chapman and Hall Publishers, London.
11. Sofowora A. Medicinal plants and tropical medicine in Africa. Spectrum Books Limited, Ibadan, Nigeria, 1984; Pp. 150–172.
12. Trease GE, Evans WC. A Textbook of Pharmacognosy, 1978; eleventh ed. Bailliere Tindall, London.
13. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976; 193: 673–675. https://doi:10.1126/science.781840
14. Lambros C, Vanderberg JP. Synchronisation of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979; 65 (3): 418-420
15. Mosmann T. Rapid colourimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.J Immunol Methods. 1983; 16: 55-63 https://doi: 10.1016/0022-1759(83)90303-4
16. Organisation for Economic Co-operation and Development (OECD). OECD Guideline for Testing Chemicals 420, 2001; Pp. 1–14.
17. Knight DJ, Peters W. The antimalarial activity of N-benzyloxydihydrotriazines: I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action. Ann Trop Med Parasitol. 1980; 74: 393–404.
18. Men TT, Huy NT, Trang DT, Shuaibu MN, Hirayama K, Kamei K. A simple and inexpensive haemozoin-based colourimetric method to evaluate antimalarial drug activity. Malar J. 2012; 11: 272. https://doi:10.1186/1475-2875-11-272
19. Peeters L, Foubert K, Bald´e MA, Tuenter E, Matheeussen A, Van Pelt N, Caljon G, Hermans N, Pieters L. Antiplasmodial activity of constituents and their metabolites after in vitro gastrointestinal biotransformation of a Nauclea pobeguinii extract. Phytochem. 2022; 194: 110329. https://doi.org/10.1016/j. phytochem.
20. Kraft C, Jenett-Siems K, Siems K, Jakupovic J, Mavi S, Bienzle U, Eich E. In vitro antiplasmodial evaluation of medicinal plants from Zimbabwe. Phytother Res. 2003; 17: 123–128. https://doi.org/10.1002/ptr.1066
21. Mesia K, Cimanga RK, Dhooghe L, Cos P, Apers S, Totté J, Tona GL, Pieters L, Vlietinck AJ, Maes L. Antimalarial activity and toxicity evaluation of a quantified Nauclea pobeguinii extract. J Ethnopharmacol. 2010; 131(1): 10-16
22. Igbi, GT, Adefunke, OO, Prosper, AE, Enudinisu, GN, Onyesom I, Ugochukwu UE. In vitro assessment of antiplasmodial and antioxidant potentials of Chrysophyllum albidum kernel extracts. TJDR 2026; 3 (Pt2): 390 – 396
23. Egan TJ. The mechanism of heme detoxification in Plasmodium falciparum. Trends Parasitol. 2008; 24(7): 305-312
24. Pagola S, Stephens PW, Bohle DS. The structure of Plasmodium falciparum heme polymerase: A new target for antimalarial drug design. Nat. 2000; 404(6773): 307-310.
25. Sullivan DJ, Gluzman IY, Goldberg DE. Plasmodium hemozoin formation mediated by histidine-rich proteins. Sci. 1996; 271(5246): 219-222.
26. Singh R, Singh R, Srihari V, Makde RD. In vitro investigation reveals new insights into the antimalarial mechanism of chloroquine: Role in perturbing nucleation events during the heme-to-β-hematin transformation. ACS Infect Dis. 2023; 9(8): 1647-1657
27. Coban C. The host targeting effect of chloroquine in malaria. Curr Opin Immunol. 2020; 66:98–10.
28. Ducharme MP, Shargel L, Yu ABC. Applied biopharmaceutics and pharmacokinetics. 8th ed. 2016; New York: McGraw-Hill Education.
29. Guenrich EP. Cytochrome P450 enzymes in the generation of commercial products. Nat Rev Drug Discov. 2018; 17(3): 145-161
30. Erhunse N, Omoregie ES, Sahal D. Antiplasmodial and antimalarial evaluation of a Nigerian hepta-herbal Agbo-iba decoction: Identification of magic bullets and possible facilitators of drug action. J Ethnopharmacol. 2023; 301: 115807. https//doi:10.1016/j.jep.2022.115807
31. Adzu B, Mustapha KB, Masimirembwa C, Obodozie O, Kirim RA, Gamaniel KS. Simulation of metabolism-based herb-drug interaction: towards safe and efficacious use of NIPRD-AM1. Avicenna J Phytomed. 2012; 3(3): 201-204.
32. Mihara K, Yamaguchi T, Takahashi Y, Kono T, Iwamoto K. Mechanisms of cytochrome P450 34A induction by artemisinin: implications for self-induced metabolism and combination therapy. Eur J Clin Pharmacol. 2020; 76(5): 721-729.
33. Enserink M. Malaria's drug miracle in danger. Sci. 2020; 328 (2010): 844-846.
34. Memvanga PB, Tona GL, Mesia K, Lusakibanza MM, Cimanga RK. Antimalarial activity of medicinal plants from the Democratic Republic of Congo: a review. J Ethnopharmacol. 2015; 169: 76–98.
35. Pousset JL. Place des médicaments traditionnels en Afrique. Trop Med. 2006; 66: 606–609.
36. Husain A, Riyazuddin M, Katekar R, Verma S, Syed AA, Singh P, Maurya R, Chattopadhyay N, Gayen JR. Herb-drug interaction studies of ethanolic extract of Cassia occidentalis L. co-administered with acetaminophen, theophylline, omeprazole, methotrexate and methylprednisolone. Phytomed Plus. 2021; 1 (2021): 100008
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
